OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 70 filers reported holding OCULAR THERAPEUTIX INC in Q4 2018. The put-call ratio across all filers is 0.78 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $353,000 | -4.1% | 71,224 | +93.3% | 0.02% | -41.4% |
| Q3 2021 | $368,000 | +59.3% | 36,840 | +126.2% | 0.03% | +52.6% |
| Q2 2021 | $231,000 | -55.0% | 16,286 | -47.9% | 0.02% | -59.6% |
| Q1 2021 | $513,000 | +105.2% | 31,263 | -4.7% | 0.05% | +193.8% |
| Q3 2020 | $250,000 | +145.1% | 32,791 | +167.6% | 0.02% | +128.6% |
| Q2 2020 | $102,000 | -26.6% | 12,252 | -39.3% | 0.01% | -30.0% |
| Q3 2018 | $139,000 | -23.2% | 20,190 | -6.8% | 0.01% | -65.5% |
| Q4 2016 | $181,000 | +40.3% | 21,663 | +57.8% | 0.03% | +163.6% |
| Q4 2015 | $129,000 | -14.6% | 13,731 | +27.5% | 0.01% | -15.4% |
| Q3 2015 | $151,000 | -54.1% | 10,772 | -31.4% | 0.01% | -64.9% |
| Q2 2015 | $329,000 | -16.1% | 15,700 | +68.0% | 0.04% | -7.5% |
| Q1 2015 | $392,000 | – | 9,348 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |